Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy

L Giovanella, L Ceriani, A Ghelfo… - Clinical …, 2007 - Wiley Online Library
Background In recent years serum thyroglobulin (Tg) measurement during thyroxine (T4)
treatment and/or after stimulation by endogenous TSH or recombinant human TSH (rhTSH) …

Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin

P Malandrino, A Latina, S Marescalco… - The Journal of …, 2011 - academic.oup.com
Context: Treatment and follow-up of patients thyroidectomized for differentiated thyroid
carcinoma (DTC) mainly depends on the identification of the patient's risk of recurrence …

High sensitive thyroglobulin assay on thyroxine therapy: can it avoid stimulation test in low and high risk differentiated thyroid carcinoma patients?

P Trimboli, D La Torre, L Ceriani… - Hormone and …, 2013 - thieme-connect.com
Thyroglobulin (Tg) is a key marker in the follow-up of differentiated thyroid cancer (DTC).
Diagnostic accuracy of serum Tg is higher after TSH stimulation than during thyroxine …

[HTML][HTML] Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper.

L Giovanella, PM Clark, L Chiovato, L Duntas… - European journal of …, 2014 - sonar.ch
English Differentiated thyroid cancer (DTC) is the most common endocrine cancer and its
incidence has increased in recent decades. Initial treatment usually consists of total …

Serum thyroglobulin measurement: clinical background and main methodological aspects with clinical impact

A Iervasi, G Iervasi, A Carpi, GC Zucchelli - Biomedicine & …, 2006 - Elsevier
It is worldwide recognized that circulating thyroglobulin (Tg) measurement represents a
fundamental tool in the follow-up of patients affected by differentiated thyroid cancer (DTC) …

Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated …

L Giovanella, L Ceriani, A Ghelfo, F Keller… - Clinical Chemistry and …, 2006 - degruyter.com
Background: Circulating human thyroglobulin (TG) measurement has a pivotal role in the
management of patients affected by differentiated thyroid cancer (DTC). Undetectable …

Assessing the utility of preoperative serum thyroglobulin in differentiated thyroid cancer: a retrospective cohort study

R Patell, A Mikhael, M Tabet, J Bena, E Berber, C Nasr - Endocrine, 2018 - Springer
Purpose Serum thyroglobulin (TG) is used to monitor for recurrence or progression of
differentiated thyroid cancer (DTC). The role of preoperative TG measurement is more …

[HTML][HTML] The role of thyroglobulin in preoperative and postoperative evaluation of patients with differentiated thyroid cancer

S Li, C Ren, Y Gong, F Ye, Y Tang, J Xu… - Frontiers in …, 2022 - frontiersin.org
Thyroglobulin (Tg) is secreted by thyroid follicular cells and stored in the thyroid follicular
lumen as a component of thyroid hormone. It is known that both benign and well …

Additional value of a high sensitive thyroglobulin assay in the follow‐up of patients with differentiated thyroid carcinoma

AH Groen, MS Klein Hesselink… - Clinical …, 2017 - Wiley Online Library
Summary Objective Thyroglobulin (Tg) is an excellent tumour marker, as detectable or
increasing Tg levels are highly indicative of persistent or recurrent differentiated thyroid …

Assay bias may invalidate decision limits and affect comparability of serum thyroglobulin assay methods: an approach to reduce interpretation differences

HA Ross, RT Netea-Maier, E Schakenraad… - Clinica Chimica …, 2008 - Elsevier
BACKGROUND: Thyroglobulin (Tg) assays are used to monitor patients after ablative
therapy for differentiated thyroid carcinoma (DTC). Detectable Tg suggests persistence or …